CausalSentinel

Protein Dossier — HTATIP2 (Protein HTATIP2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Height -0.0194 0.00537 3.05e-04 Wald ratio 1 trans NA
Non-cancer illness code self-reported: sleep apnoea 0.197 0.066 0.00291 Wald ratio 1 trans NA
Birth weight -0.0179 0.00657 0.00639 Wald ratio 1 trans NA
Diagnoses - main ICD10: N81 Female genital prolapse -0.111 0.0415 0.00744 Wald ratio 1 trans NA
Body mass index (BMI) 0.0116 0.00443 0.00908 Wald ratio 1 trans NA
Non-cancer illness code self-reported: osteoporosis -0.0805 0.0386 0.0372 Wald ratio 1 trans NA
Non-cancer illness code self-reported: bladder problem (not cancer) 0.109 0.0523 0.0373 Wald ratio 1 trans NA
Cancer code self-reported: malignant melanoma -0.116 0.0567 0.0403 Wald ratio 1 trans NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0419 0.0206 0.0417 Wald ratio 1 trans NA
Years of schooling -0.0149 0.00746 0.0455 Wald ratio 1 trans NA
Non-cancer illness code self-reported: retinal detachment 0.134 0.0679 0.0483 Wald ratio 1 trans NA
Non-cancer illness code self-reported: polio or poliomyelitis 0.255 0.134 0.0569 Wald ratio 1 trans NA
…and 79 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

37 association rows across 26 traits (21 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Oxidoreductase HTATIP2 levels 1e-1325 rs10437608 2 GCST90248807 no MR -> candidate analysis
Bone mineral density mean 1e-300 rs79753040 2 GCST90321120 no MR -> candidate analysis
Height 1e-27 rs11025443 6 GCST90245848 MR: beta=-0.0194, p=3.05e-04 (trans)
Severe COVID-19 infection 6e-17 rs11025535 3 GCST90255357 no MR -> candidate analysis
Height (baseline) 5e-13 rs35081743 1 GCST90565843 no MR -> candidate analysis
Response to inhaled glucocorticoid treatment in asthma (chan 6e-11 rs1353649 1 GCST002754 no MR -> candidate analysis
Free Cholesterol to Cholesteryl Esters in Large HDL ratio 4e-10 rs117384644 1 GCST90827800 no MR -> candidate analysis
Gut microbial network clusters (Salmon (at 1 year) x Househo 2e-9 rs11826915 1 GCST90569475 no MR -> candidate analysis
Physical function (baseline) 2e-8 rs35081743 1 GCST90565837 no MR -> candidate analysis
Cerebrospinal fluid t-tau:AB1-42 ratio 3e-8 rs7129826 1 GCST004490 no MR -> candidate analysis
Gut microbiome abundance (class Collinsella sp. 3 (at 1 year 3e-8 rs34236148 1 GCST90568927 no MR -> candidate analysis
Fractional shortening 4e-8 rs11025521 1 GCST006029 no MR -> candidate analysis
…and 14 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 145 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
COVID-19 0.557 common-variant locus no MR -> candidate analysis
severe acute respiratory syndrome 0.557 common-variant locus no MR -> candidate analysis
liver disorder 0.425 common-variant locus no MR -> candidate analysis
placental abruption 0.425 common-variant locus no MR -> candidate analysis
injury 0.053 common-variant locus MR: beta=-0.174, p=0.198 (trans)
atrial fibrillation 0.05 common-variant locus MR: beta=-0.0479, p=0.278 (trans)
response to glucocorticoid 0.049 common-variant locus no MR -> candidate analysis

Of the 7 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=6.2e-10, LOEUF=1.46 — LoF-tolerant
GWAS Catalog 40 unique SNPs / 74 rows
ClinVar 69 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance